Osteoblastic Differentiation Is Enhanced by Rapamycin in Rat Osteoblast-like Osteosarcoma (ROS 17/2.8) Cells
- 1 August 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 249 (1) , 226-230
- https://doi.org/10.1006/bbrc.1998.9118
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- Retinoids modify regulation of endogenous gene expression by vitamin D3 and thyroid hormone in three osteosarcoma cell lines.Endocrinology, 1995
- THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1Transplantation, 1993
- Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitroCalcified Tissue International, 1992
- Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinaseNature, 1992
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrixJournal of Cellular Physiology, 1990
- Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridizationThe Journal of cell biology, 1988
- Functional Properties of Hormonally Responsive Cultured Normal and Malignant Rat Osteoblastic Cells*Endocrinology, 1981
- Parathyroid Hormone-Responsive Clonal Cell Lines from Rat Osteosarcoma*Endocrinology, 1980